newsfilter
← Latest News
GlobeNewswire·

Lumos Pharma to Participate in Oppenheimer's 33rd Annual Healthcare Conference Held Virtually March 13-15, 2023

AUSTIN, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2